AGENUS INC — Director's Dealing 2010

Apr 28, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-04-26

Reporting Person: Valentine Karen (VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-04-26	Common Stock	A	2500	$1.19	Acquired	53991	Direct

Footnotes

F1: Represents settlement of restricted stock awarded on January 26, 2010.